Page 147 - Pharmacy Appeals 1/4/04 to 31/3/05
P. 147
NHS Resolution Annual report and accounts 2021/22 123
Expenditure continued Notes 2021/22 2020/21
(£000s) (£000s)
Consultancy 0 0
External corporate legal fees5 188 165
Practitioner Performance Advice 182 97
assessment expenditure
Practitioner Performance Advice 0 0
professional services
Other 1,156 508
Auditor's remuneration: audit fees6 250 225
Internal audit fees 63 68
Bank charges and interest 13 10
43,317 34,458
Depreciation 454 558
Amortisation 376 376
Loss on disposal 20 48
Impairment 36 0
886 982
44,203 35,440
Other finance costs - unwinding of discount 7 347,620 503,375
Increase in provision for known claims 7 6,174,216 3,828,662
(excl. unwinding of discounts and
change in discount rate)
Change in the discount rate7 7 42,623,207 228,701
lncrease/(decrease) in the provision for IBNR 7 (3,378,795) (3,902,000)
45,766,248 658,738
Total expenditure8 45,810,452 694,178
5 External corporate legal fees do not include legal fees in relation to clinical and non-clinical claims. These costs are included within Note 7 Provisions.
6 NHS Resolution did not make any payments to its auditors for non-audit work.
7 The discount rates used are mandated by HM Treasury and are set out at Note 7.3 to the accounts.
s Of the £44.2 million total expenditure for 2021/21, £5.5 million is shown as administration expenditure in DHSC consolidated group accounts.